Monash vs Notre Dame Fremantle

UCAT-ANZ cut-offs. Monash — Direct Entry only. 2026 entry December round cut-off ~2380/2700 (~94th percentile, post-rebase). 2023 entry on old /3600 scale was ~2990 non-rural / ~2620 rural — not directly comparable due to 2024… Notre Dame Fremantle — no published cut-off.

GAMSAT cut-offs. Monash — NOT required. Removed from Graduate Entry selection in 2017; never used for Direct Entry. Notre Dame Fremantle — Minimum 52 overall + 50 in each subsection (UNDA averages the three sections rather than using the overall weighted GAMSAT). 2023 intake average successful GAMSAT 66 (3-year avg ~60+).

Timing shapes the choice as much as the score. GAMSAT is graduate-only and sits in March and September; UCAT-ANZ is mostly undergraduate and sits in July. A few schools run their own selection model with no national test at all.

Monash requires Direct Entry: ATAR minimum 90 (competitive typically ≥99.45) + UCAT-ANZ + MMI; VCE English (study score 35 EAL or 30 English) and Chemistry (30) prerequisites.

Graduate Entry: Monash undergraduate degree (Bachelor of Biomedical Science, Pharmacy Hons, Physiotherapy Hons, designated BSc units, or Federation Uni Bachelor of Biomedical Science via Gippsland Partnership) with WAM ≥ 70 + MMI + SJT. No GAMSAT for grad pathway since 2017.

Notre Dame Fremantle requires Bachelor degree with minimum GPA 5.2/7.0; GAMSAT 52 overall + 50 in each subsection (unweighted average of 3 sections); CASPer; MMI (Modern Hire asynchronous).

ATAR. Monash — Direct Entry minimum ATAR 90; competitive typically ≥99.45. Notre Dame Fremantle — no published cut-off.

Graduate-entry GPA. Monash — Graduate Entry: WAM minimum 70. Lowest accepted WAM (2025 cycle, student-reported) 81.179. Notre Dame Fremantle — Minimum 5.2/7.0. 2023 intake average successful GPA 6.70 (3-year avg ~6.7); competitive ≥6.3.

Read every ATAR figure as a selection rank, not a raw score. Educational access bonuses, rural-origin uplift and Indigenous pathways all adjust it, so the published number is rarely the one that decides your application.

Both Monash and Notre Dame Fremantle use MMI interviews, so the underlying prep approach is the same — practise ethics frameworks, Australian health-system topics (Medicare, rural workforce, Indigenous health) and (for MMI) structured station responses against a timer.

That said, the specifics differ slightly: Monash runs multi-mini interview (8 stations × 8 min, 2 min reading); Notre Dame Fremantle runs mmi (asynchronous online via modern hire). Mock practice tailored to each school's exact format is the highest-leverage prep.

Interview windows: Monash interviews in October-December; Notre Dame Fremantle in September-November.

Both schools deliver a Integrated-style curriculum, so day-to-day study habits will feel similar across years 1-3.

Specifics: Direct Entry 5-year MD: years 1-2 foundations and clinical skills at Clayton; years 3-5 clinical placements across Monash Health, Peninsula, and rural 4-year graduate MD. Years 1-2 foundations and clinical skills at Fremantle with early clinical immersion. Years 3-4 hospital and rural placements acro

Intake size: Monash — Direct Entry (Clayton): ~264 domestic (234 + 30 ERC). Graduate Entry (Gippsland): ~70 domestic + 30 Rural End-to-End + ~30 international. Total combined ~390+ (Fraser's Monash MD 2027 guide).; Notre Dame Fremantle — 2027 cycle ~127 total: 80 CSP (60 Fremantle + 20 KCRMT Broome) + 32 BMP + up to 15 international + uncapped Indigenous.

Significant +17 expansion vs 2026 (110) driven by KCRMT Broome pathway and Commonwealth Indigenous policy change.. A larger cohort means more peer breadth; a smaller cohort means more tutor contact.

Monash: Not publicly disclosed. Notre Dame Fremantle: Not publicly disclosed; aggregator estimate ~200-250 interviewed for ~100 places.

Post-interview odds give you the clearest signal of how competitive each school is at the final stage — a school with a 60% post-interview success rate is structurally easier to convert than one at 25%, even if the interview thresholds look identical on paper.

Monash: Monash runs a dual-pathway MD: Direct Entry (M6011, 5-year BMedSc+MD at Clayton, UCAT-ANZ + ATAR) and Graduate Entry (4-year MD at Gippsland / Churchill campus). Graduate Entry MD requires Monash undergraduate study (closed to external grads since 2017 GAMSAT removal); no GAMSAT required for the graduate pathway.

The Direct Entry December round uses UCAT-only ranking before ATAR is released; the January round uses combined UCAT + ATAR.

Notre Dame Fremantle: Notre Dame Fremantle replaced its portfolio + panel system with CASPer from the 2024 intake — one of the heaviest CASPer weightings in Australian medicine (30% of pre-interview composite). 2027 cycle introduces 20 new CSP places at the Kimberley Centre for Rural and Remote Medicine and Training (KCRMT) Broome — Kimberley-region remote-workforce expansion.

From 1 January 2026 Indigenous CSP allocation is uncapped (Commonwealth policy change). Assured Pathway: from 2024, 40 places nationally (20 Fremantle + 20 Sydney) reserved for Assured Pathway undergraduate pre-MD applicants.